In vitro amplification of misfolded prion protein using lysate of cultured cells

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Mays, Charles E ^a,d   Yeom, Jihyun ^b   Kang, Hae Eun ^b   Bian, Jifeng ^b   Khaychuk, Vadim ^a   Kim, Younghwan ^b,e   Bartz, Jason C ^c   Telling, Glenn C ^a,b   Ryou, Chongsuk ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN; RECOMBINANT PROTEIN; CELL EXTRACT;

ANIMAL CELL; ARTICLE; ASSAY; BACTERIAL CELL; CELL LYSATE; CELL STRAIN; CELL STRAIN RK13; CONTROLLED STUDY; GENE; GENE AMPLIFICATION; GENETIC TRANSFECTION; IN VITRO STUDY; KIDNEY CELL; KIDNEY EPITHELIUM; MAMMAL CELL; MOUSE; NERVE CELL; NONHUMAN; PRION PROTEIN GENE; PROTEIN DEFECT; PROTEIN FOLDING; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; PROTEIN PURIFICATION; ANIMAL; BIOCHEMISTRY; CELL CULTURE; GENETICS; HAMSTER; METABOLISM; METHODOLOGY; OPEN READING FRAME; PRION; RABBIT;

ANIMALIA; BACTERIA (MICROORGANISMS); MAMMALIA; MESOCRICETUS AURATUS; ORYCTOLAGUS CUNICULUS;

ANIMALS; BIOCHEMISTRY; CELL EXTRACTS; CELLS, CULTURED; CRICETINAE; MICE; NEURONS; OPEN READING FRAMES; PRIONS; PROTEIN FOLDING; PRPSC PROTEINS; RABBITS;

EID: 79953141283     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018047     Document Type: Article

References (61)

1. Prusiner SB, (1998) Prions. Proc Natl Acad Sci USA 95: 13363-13383.
2. Prusiner SB, (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144.
3. Ryou C, Mays CE, (2008) Prion propagation in vitro: are we there yet? Int J Med Sci 5: 347-353.
4. Saborio GP, Permanne B, Soto C, (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411: 810-813.
5. Castilla J, Saa P, Hetz C, Soto C, (2005) In vitro generation of infectious scrapie prions. Cell 121: 195-206.
6. Castilla J, Saá P, Morales R, Abid K, Maundrell K, et al. (2006) Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods in Enzymology Academic Press pp. 3-21.
7. Shikiya RA, Ayers JI, Schutt CR, Kincaid AE, Bartz JC, (2010) Coinfecting prion strains compete for a limiting cellular resource. J Virol 84: 5706-5714.
8. Castilla J, Gonzalez-Romero D, Saá P, Morales R, De Castro J, et al. (2008) Crossing the species barrier by PrPSc replication in vitro generates unique infectious prions. Cell 134: 757-768.
9. Green KM, Castilla J, Seward TS, Napier DL, Jewell JE, et al. (2008) Accelerated high fidelity prion amplification within and across prion species barriers. PLoS Pathog 4: e1000139.
10. Meyerett C, Michel B, Pulford B, Spraker TR, Nichols TA, et al. (2008) In vitro strain adaptation of CWD prions by serial protein misfolding cyclic amplification. Virology 382: 267-276.
11. Kurt TD, Telling GC, Zabel MD, Hoover EA, (2009) Trans-species amplification of PrPCWD and correlation with rigid loop 170N. Virology 387: 235-243.
12. Weber P, Giese A, Piening N, Mitteregger G, Thomzig A, et al. (2007) Generation of genuine prion infectivity by serial. Vet Microbiol 123: 346-357.
13. Barria MA, Mukherjee A, Gonzalez-Romero D, Morales R, Soto C, (2009) De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog 5: e1000421.
14. Deleault NR, Lucassen RW, Supattapone S, (2003) RNA molecules stimulate prion protein conversion. Nature 425: 717-720.
15. Lucassen R, Nishina K, Supattapone S, (2003) In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups. Biochemistry 42: 4127-4135.
16. Kim N-H, Choi J-K, Jeong B-H, Kim J-I, Kwon M-S, et al. (2005) Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres. FASEB J 19: 783-785.
17. Nishina KA, Deleault NR, Mahal SP, Baskakov I, Luhrs T, et al. (2006) The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro. Biochemistry 45: 14129-14139.
18. Murayama Y, Yoshioka M, Yokoyama T, Iwamaru Y, Imamura M, et al. (2007) Efficient in vitro amplification of a mouse-adapted scrapie prion protein. Neurosci Lett 413: 270-273.
19. Deleault NR, Harris BT, Rees JR, Supattapone S, (2007) Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 104: 9741-9746.
20. Geoghegan JC, Valdes PA, Orem NR, Deleault NR, Williamson RA, et al. (2007) Selective incorporation of polyanionic molecules into hamster prions. J Biol Chem 282: 36341-36353.
21. Mays CE, Titlow W, Seward T, Telling GC, Ryou C, (2009) Enhancement of protein misfolding cyclic amplification by using concentrated cellular prion protein source. Biochem Biophys Res Commun 388: 306-310.
22. Kim J-I, Surewicz K, Gambetti P, Surewicz WK, (2009) The role of glycophosphatidylinositol anchor in the amplification of the scrapie isoform of prion protein in vitro. FEBS Lett 583: 3671-3675.
23. Abid K, Morales R, Soto C, (2010) Cellular factors implicated in prion replication. FEBS Lett 584: 2409-2414.
24. Mays CE, Ryou C, (2010) Plasminogen stimulates propagation of protease-resistant prion protein in vitro. FASEB J 24: 5102-5112.
25. Soto C, Anderes L, Suardi S, Cardone F, Castilla J, et al. (2005) Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett 579: 638-642.
26. Castilla J, Saa P, Soto C, (2005) Detection of prions in blood. Nat Med 11: 982-985.
27. Gonzalez-Romero D, Barria MA, Leon P, Morales R, Soto C, (2008) Detection of infectious prions in urine. FEBS Lett 582: 3161-3166.
28. Kurt TD, Perrott MR, Wilusz CJ, Wilusz J, Supattapone S, et al. (2007) Efficient in vitro amplification of chronic wasting disease PrPRES. J Virol 81: 9605-9608.
29. Jones M, Peden AH, Prowse CV, Gröner A, Manson JC, et al. (2007) In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J Pathol 213: 21-26.
30. Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, et al. (2007) Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 4: 645-650.
31. Jones M, Peden AH, Yull H, Wight D, Bishop MT, et al. (2009) Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrPSc) associated with variant Creutzfeldt-Jakob disease. Transfusion 49: 376-384.
32. Thorne L, Terry LA, (2008) In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie. J Gen Virol 89: 3177-3184.
33. Haley NJ, Mathiason CK, Zabel MD, Telling GC, Hoover EA, (2009) Detection of sub-clinical CWD infection in conventional test-negative deer long after oral exposure to urine and feces from CWD+ deer. PLoS ONE 4: e7990.
34. Tattum MH, Jones S, Pal S, Collinge J, Jackson GS, (2010) Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification. Transfusion 50: 996-1002.
35. Rubenstein R, Chang B, Gray P, Piltch M, Bulgin MS, et al. (2010) A novel method for preclinical detection of PrPSc in blood. J Gen Virol 91: 1883-1892.
36. Balkema-Buschmann A, Eiden M, Hoffmann C, Kaatz M, Ziegler U, et al. (2010) BSE infectivity in the absence of detectable PrPSc accumulation in the tongue and nasal mucosa of terminally diseased cattle. J Gen Virol DOI:10.1099/vir.1090.025387-025380.
37. Murayama Y, Yoshioka M, Masujin K, Okada H, Iwamaru Y, et al. (2010) Sulfated dextrans enhance in vitro amplification of bovine spongiform encephalopathy PrPSc and enable ultrasensitive detection of bovine PrPSc. PLoS ONE 5: e13152.
38. Nishina K, Deleault NR, Lucassen RW, Supattapone S, (2004) In vitro prion protein conversion in detergent-solubilized membranes. Biochemistry 43: 2613-2621.
39. Graham JF, Agarwal S, Kurian D, Kirby L, Pinheiro TJT, et al. (2010) Low density subcellular fractions enhance disease-specific prion protein misfolding. J Biol Chem 285: 9868-9880.
40. Gorodinsky A, Harris DA, (1995) Glycolipid-anchored proteins in neuroblastoma cells form detergent-resistant complexes without caveolin. J Cell Biol 129: 619-627.
41. Naslavsky N, Stein R, Yanai A, Friedlander G, Taraboulos A, (1997) Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem 272: 6324-6331.
42. Vey M, Pilkuhn S, Wille H, Nixon R, DeArmond SJ, et al. (1996) Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci USA 93: 14945-14949.
43. Geoghegan JC, Miller MB, Kwak AH, Harris BT, Supattapone S, (2009) Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Pathog 5: e1000535.
44. Kim J-I, Cali I, Surewicz K, Kong Q, Raymond GJ, et al. (2010) Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 285: 14083-14087.
45. Wang F, Wang X, Yuan C-G, Ma J, (2010) Generating a prion with bacterially expressed recombinant prion protein. Science 327: 1132-1135.
46. Saborio GP, Soto C, Kascsak RJ, Levy E, Kascsak R, et al. (1999) Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone. Biochem Biophys Res Commun 258: 470-475.
47. Bian J, Napier D, Khaychuck V, Angers R, Graham C, et al. (2010) Cell-based quantification of chronic wasting disease prions. J Virol 84: 8322-8326.
48. Klebe RJ, Ruddle FH, (1969) Neuroblastoma: cell culture analysis of a differentiating stem cell system. J Cell Biol 43: 69a.
49. Birkett CR, Hennion RM, Bembridge DA, Clarke MC, Chree A, et al. (2001) Scrapie strains maintain biological phenotypes on propagation in a cell line in culture. EMBO J 20: 3351-3358.
50. Mays CE, Kang H-E, Kim Y, Shim SH, Bang J-E, et al. (2008) CRBL cells: Establishment, characterization and susceptibility to prion infection. Brain Res 1208: 170-180.
51. Jainchill JL, Aaronson SA, Todaro GJ, (1969) Murine sarcoma and leukemia viruses: Assay using clonal lines of contact-inhibited mouse cells. J Virol 4: 549-553.
52. Bessen RA, Marsh RF, (1992) Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol 73: 329-334.
53. Stahl N, Borchelt DR, Prusiner SB, (1990) Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase C. Biochemistry 29: 5405-5412.
54. Yanai A, Meiner Z, Gahali I, Gabizon R, Taraboulos A, (1999) Subcellular trafficking abnormalities of a prion protein with a disrupted disulfide loop. FEBS Lett 460: 11-16.
55. Leblanc P, Alais S, Porto-Carreiro I, Lehmann S, Grassi J, et al. (2006) Retrovirus infection strongly enhances scrapie infectivity release in cell culture. EMBO J 25: 2674-2685.
56. Deleault NR, Geoghegan JC, Nishina K, Kascsak R, Williamson RA, et al. (2005) Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J Biol Chem 280: 26873-26879.
57. Deleault NR, Kascsak R, Geoghegan JC, Supattapone S, (2010) Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry 49: 3928-3934.
58. Shi S, Dong C-F, Wang G-R, Wang X, An R, et al. (2009) PrPSc of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification. Virus Res 141: 26-33.
59. Beale AJ, Christofins GC, Furminger IGS, (1963) Rabbit cells susceptible to rubellar virus. Lancet 2: 640-641.
60. Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, et al. (1999) Prions prevent neuronal cell-line death. Nature 400: 225-226.
61. Courageot M-P, Daude N, Nonno R, Paquet S, Di Bari MA, et al. (2008) A cell line infectible by prion strains from different species. J Gen Virol 89: 341-347.